ARCHIVES

The Line Item for Cancer Centers and SPOREs to Remain Flat, Near $598 Million for the 2013 Fiscal Year

This article is from The Cancer Letter archive.

Vol. 38 No. 16 | April 20, 2012

Download PDF Visit The Full Archive

Related Articles

Olaparib Study Demonstrates No Changes In Overall Survival

March 30, 2012

Survival Rates Same For Two Treatments For Eye Cancer: Radiation Or Removal

July 27, 2001

In Brief: Ross, Harvey To Lead Cancer Center Group; NCI Director In Office By Aug. 1, Varmus Says

May 19, 1995

The Meeting Worth Lobbying For: A “PRG” For Disease-Specific Review; NCI Plans Six.

June 23, 2000

Blistering Resignation Letters Declare CPRIT Outside Mainstream of Science

October 12, 2012

CCOP Controversy Goes On: DCT Board Objects, Says It Was Left Out; Moorhead, DeVita Clarify Positions

February 19, 1982